Page last updated: 2024-11-05

luteoskyrin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Luteoskyrin is a mycotoxin produced by the fungus Aspergillus flavus, which is known to contaminate various food products. It is a highly toxic compound with potent hepatotoxic, carcinogenic, and immunosuppressive properties. Luteoskyrin's biosynthesis involves a complex pathway with multiple enzymatic steps, including the formation of a bisanthraquinone structure. Its carcinogenic activity is attributed to its ability to induce DNA damage and oxidative stress, leading to mutations and cell transformation. Luteoskyrin's immunosuppressive effects are linked to its interference with immune cell signaling pathways. Research on luteoskyrin focuses on understanding its mechanisms of toxicity, developing methods for its detection and detoxification, and exploring its potential applications in medicine and agriculture. Due to its potential health risks, luteoskyrin contamination of food products is a major concern, leading to efforts for its control through agricultural practices and food processing techniques.'

luteoskyrin: mycotoxin from Penicillium islandicum; pollutant of stored rice; minor descriptor (75-85); on-line & Index Medicus search NAPHTHOQUINONES (75-85); RN given refers to (1S,1'S,2R,2'R,3S,3'S,9aR,9'aR)-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID30840
CHEMBL ID2003746
CHEBI ID80711
SCHEMBL ID846545
MeSH IDM0263067

Synonyms (22)

Synonym
5h,13a,5a,14-[1,2,3,4]butanetetraylcycloocta[1,2-b:5,6-b']dinaphthalene-5,8,13,16(14h)-tetrone, 1,4,7,9,12,15,17,20-octahydroxy-3,11-dimethyl-
8,8'-dihydroxyrugulosin
luteoskyrin
rugulosin,8'-dihydroxy-, (1s,1's,2r,2'r,3s,3's,9ar,9'ar)-
rugulosin,8'-dihydroxy-
(-)-luteoskyrin
rugulosin,8'-dehydroxy-
nsc160879 ,
octahydroxy(dimethyl)[?]tetrone
luteoskyrin, (-)
NCI60_001196
MLS004491708
smr003288669
SCHEMBL846545
CHEBI:80711 ,
5h,6h-6,13a,5a,14-[1,2,3,4]butanetetraylcycloocta[1,2-b:5,6-b']dinaphthalene-5,8,13,16(14h)-tetrone, 1,4,7,9,12,15,17,20-octahydroxy-3,11-dimethyl-
KXNUPFFSGSRABD-UHFFFAOYSA-N
CHEMBL2003746
DTXSID0020787
Q27149746
Q2110317
5,8,10,14,20,23,25,28-octahydroxy-6,21-dimethyloctacyclo[14.11.1.02,11.02,15.04,9.013,17.017,26.019,24]octacosa-4,6,8,10,19,21,23,25-octaene-3,12,18,27-tetrone

Research Excerpts

Overview

Luteoskyrin is a bis-dihydroanthraquinone mycotoxin produced by Penicillium islandicum Sopp.

ExcerptReferenceRelevance
"Luteoskyrin is a hepatotoxic and hepatocarcinogenic bisdihydroanthraquinone produced by Penicillium islandicum Sopp. "( Spin-trapping and direct EPR investigations on the hepatotoxic and hepatocarcinogenic actions of luteoskyrin, an anthraquinoid mycotoxin produced by Penicillium islandicum Sopp. Generations of superoxide anion and luteoskyrin semiquinone radical in the re
Hoshino, M; Ohya-Nishiguchi, H; Sekijima, M; Ueno, I; Ueno, Y, 1995
)
1.95
"Luteoskyrin is a bis-dihydroanthraquinone mycotoxin produced by Penicillium islandicum Sopp. "( Luteoskyrin, an anthraquinoid hepatotoxin, and ascorbic acid generate hydroxyl radical in vitro in the presence of a trace amount of ferrous iron.
Hoshino, M; Kanegasaki, S; Maitani, T; Ueno, I; Ueno, Y, 1993
)
3.17
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (19)

TimeframeStudies, This Drug (%)All Drugs %
pre-199010 (52.63)18.7374
1990's7 (36.84)18.2507
2000's2 (10.53)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 25.76

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index25.76 (24.57)
Research Supply Index3.04 (2.92)
Research Growth Index4.13 (4.65)
Search Engine Demand Index29.35 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (25.76)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (5.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other19 (95.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]